000			01323 a2200385 4500
005			20250512092538.0
264		0	_c19670819
008			196708s 0 0 eng d
022			_a0140-6736
024	7		_a10.1016/s0140-6736(67)91590-5 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrumfitt, W
245	0	0	_aClinical and laboratory studies with carbenicillin. A new penicillin active against Pseudomonas pyocyanea. _h[electronic resource]
260			_bLancet (London, England) _cJun 1967
300			_a1289-93 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aEscherichia coli Infections _xdrug therapy
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPenicillin Resistance
650	0	4	_aPenicillins _xtherapeutic use
650	0	4	_aPeritonitis _xdrug therapy
650	0	4	_aPseudomonas Infections _xdrug therapy
650	0	4	_aRespiratory Tract Infections _xdrug therapy
650	0	4	_aUrinary Tract Infections _xdrug therapy
700	1		_aPercival, A
700	1		_aLeigh, D A
773	0		_tLancet (London, England) _gvol. 1 _gno. 7503 _gp. 1289-93
856	4	0	_uhttps://doi.org/10.1016/s0140-6736(67)91590-5 _zAvailable from publisher's website
999			_c4170813 _d4170813